Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 2.20% |
| Q3 2025 | -0.07% |
| Q2 2025 | -6.96% |
| Q1 2025 | 0.10% |
| Q4 2024 | 6.10% |
| Q3 2024 | 6.88% |
| Q2 2024 | 8.49% |
| Q1 2024 | 7.77% |
| Q4 2023 | 9.28% |
| Q3 2023 | 9.45% |
| Q2 2023 | -15.76% |
| Q1 2023 | 5.35% |
| Q4 2022 | 13.37% |
| Q3 2022 | 6.08% |
| Q2 2022 | 8.30% |
| Q1 2022 | 8.28% |
| Q4 2021 | -29.18% |
| Q3 2021 | 3.81% |
| Q2 2021 | 2.79% |
| Q1 2021 | -2.81% |
| Q4 2020 | 6.34% |
| Q3 2020 | 7.25% |
| Q2 2020 | 10.38% |
| Q1 2020 | 10.10% |
| Q4 2019 | 10.55% |
| Q3 2019 | 12.64% |
| Q2 2019 | 4.76% |
| Q1 2019 | 3.89% |
| Q4 2018 | 6.85% |
| Q3 2018 | 6.30% |
| Q2 2018 | 12.54% |
| Q1 2018 | 12.20% |
| Q4 2017 | 119.79% |
| Q3 2017 | 30.07% |
| Q2 2017 | 32.96% |
| Q1 2017 | 18.80% |
| Q4 2016 | 30.94% |
| Q3 2016 | 21.09% |
| Q2 2016 | 26.80% |
| Q1 2016 | 8.59% |